Inspur Electronic Information Showcases Industry-Leading Server Solutions and Applications for Intelligent Manufacturing Transformation at Hannover Messe 2023
14.4.2023 10:09:00 EEST | Business Wire | Press release
Inspur Electronic Information, a leading IT infrastructure solutions provider, will attend Hannover Messe 2023 from April 17-21. With a main theme of “Intelligent IT transformation for Manufacturing,” the company will bring its latest and innovative G7 server family, liquid cooling servers, and edge servers that support recent customer cases in manufacturing and drive the digitalization of manufacturing customers throughout Europe.
Inspur Electronic Information will join around 4,000 companies from the mechanical engineering, electrical, and digital industries. Industry leaders would gather to share their insights on topics including digital platform, cloud & infrastrucuture, and digital energy & energy efficiency.
Inspur Electronic Information believes that the digitization and optimization of manufacturing is the first step of Industry 4.0, a process where traditional enterprises constantly introduce digital and intelligent technologies and conduct production technology and model innovations based on those technologies in production. This deepens the digital and intelligent integration of supply chain, warehouse, manufacturing, quality control, logistics, delivery, service and other links. Therefore, manufacturing enterprises need a stable, reliable, efficient, green, and dynamically scalable IT infrastructure that can provide trusted business assurance, cost efficiency, and adaptability.
G7 server family, liquid cooling and edge hardware for intelligent manufacturing applications
Inspur Electronic Information has industry-leading computing platform solutions and expansive deployment experiences. At Hannover Messe 2023, the company will bring G7 servers, liquid cooling servers, and edge servers with the newest improvement in reliability, flexibility and sustainability. These products meet computing requirements in different environments and scenarios, such as data center and edge, and provide manufacturing enterprises with reliable, flexible, and efficient intelligent manufacturing IT architecture solutions.
The latest G7 server family will be the highlight at the exhibit, with NF5266G7, NF5280G7, and NF5688G7 making an appearance. The G7 platform delivers an 86% computing performance improvement compared to the previous-generation. G7 server management module, memory module, network module, and other modules are designed based on open standards and compatible with DC-SCM management module. The open design further improves flexible scalability of the systems. The G7 platform offers reliability from firmware to hardware. Core components such as power supply, BIOS, and BMC adopt full redundancy design. Up to 95% fault diagnosis accuracy is achieved through cloud operation and maintenance. The G7 platform can be equipped with liquid cooling to lower the PUE as low as 1.1 and features excellent flexibility, energy-savings, and reliability, better facilitating the key applications for intelligent manufacturing transformation.
- NF5280G7 is a datacenter full-scene adaptable rack server that has flexible PCle expansion with OCP NIC 3.0 slots and 4 dual-width GPUs. It is especially suitable for ERP, CRM, MES, WMS, and other intelligent manufacturing scenarios, as well as small and medium-sized databases, big data analysis, and other intelligent manufacturing key systems, both on-premise and cloud deployment.
- NF5688G7 is the next-gen AI training server suitable for the most demanding industry design and intelligent manufacturing tasks, like the trillion-parameter Transformer model training. It supports eight 700w GPUs and flexible PCIe extensions using CX7, OCP3.0, and SmartNICs, delivering industry-leading performance, I/O expansion, and energy efficiency.
- The high-density storage server NF5266G7 features a three-tier storage architecture to optimize balance between computing and storage I/O capabilities. It is highly suitable for data analytics, data archive, video storage and processing, cloud storage pool, and other application scenarios in the manufacturing industry.
Carbon reduction in manufacturing is also an important requirement in the era of Industry 4.0. Inspur Electronic Information has increased its push for energy consumption reduction in data centers by launching full-stack liquid-cooled server solutions, helping users fulfill their sustainable development goals. Representing the company’s liquid cooling lineup will be the high-density multi-node server i24LM6 that will be showcased on-site. This system can adapt to various environments, including high temperatures and high altitudes, and provides exceptional cooling performance for CPUs with high power consumption. With warm-water cooling technology and a CPU+VR+DIMM liquid-cooling plate, it has a PUE below 1.1, which significantly reduces cooling costs.
The amount of data being generated and the amount of data requiring processing on edge is increasing exponentially. Inspur Electronic Information has developed a comprehensive edge server portfolio featuring outstanding performance, great environmental adaptability, and flexible scalability, to support the development of Industry 4.0 from cloud, edge, and data centers. EIS200, which will be displayed on site, is a lightweight edge AI computing product, providing edge computing power up to 21TOPS while only consuming 25W. The system is suitable for industrial quality inspection and other scenarios.
Deep Technology Integration to Transform the Manufacturing Industry
Inspur Electronic Information has long supported the manufacturing industry and has provided computing technologies for automotive design and simulation, automotive manufacturing, operation and maintenance management, and more for top European automotive manufacturers. It recently provided an HPC as a Service (HPCaaS) solution for computer-aided engineering (CAE) to an auto manufacturer in Europe, together with NEC Deutschland. The joint solution offers largely-enhanced HPC performance with low power consumption and TCO, accelerating the manufacturer along the path towards digitalization and industry upgrade.
When: 17-21 April, 2023
Where: Hannover Messegelände, Germany, Hall 14, Stand #J61.
About Inspur Electronic Information
Founded in 1998, Inspur Electronic Information Industry Co Ltd is the world's leading provider of IT infrastructure products, solutions, and services. Its business focuses on three major fields: servers, storage and networks. It has 8 R&D centers, 10 production bases, and 26 branches covering more than 120 countries and regions. Inspur Electronic Information is committed to the innovation of digital technology along with the application and integration of digital worlds with the physical world. It is helping enterprises embark on a path of sustainable development by driving intelligent digital transformation. To learn more, visit https://www.ieisystem.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230414005115/en/
Contact information
Fiona Liu
Inspur Electronic Information
liuxuan01@ieisystem.com
Constanze Kreil
Allison+Partners
constanze.kreil@allisonpr.com
+49 (0)151 210 289 97
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
